Research Project ManagerMemorial Sloan Kettering Cancer CenterNew York, New York, United States
Disclosure information not submitted.
LB803 - The Cost Effectiveness of Total Neoadjuvant Therapy with Selective Nonoperative Management: An Analysis Based on the OPRA Trial
Monday, June 3, 20244:02 PM – 4:08 PM ET, USA